RPRX
RPRX
GB00BMVP7Y09
Royalty Pharma plc
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 2.378.193.000 2.263.576.000
5.1%
Cost of Revenue -- --
--
Gross Profit -- --
--
818.675.000 971.132.000
15.7%
Operating Income 1.559.518.000 1.292.444.000
20.7%
Pretax Income 1.324.192.000 1.330.813.000
0.5%
Net Income Common Stockholders 770.947.000 858.983.000
10.2%
-- --
--
-- --
--
ende